2seventy Bio Inc (TSVT) Live Share Price, Invest From India

2seventy Bio Inc Stock Performance

as on May 13, 2025 at 6:59 am IST

$4.99
Day's Price Range
$4.99
$4.99
52 Week's Low
52 Week's High
$4.88
52-Week Price Range
$5.01
$4.99
2.20%
Downside
0.40%
Upside

2seventy Bio Inc share price movements today

Previous Close: $4.99
Open: $4.99
Volume: 1.2K
Day's Low - High: $4.99 - $4.99
52 Week Low - High: $4.88 - $5.01

2seventy Bio Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

2seventy Bio Inc Stock Fundamentals & Key Indicators

Check 2seventy Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

2seventy Bio Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of 2seventy Bio Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
2seventy Bio Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on 2seventy Bio Inc Stock

Based on 14 analysts

BUY

57.14%

Buy

42.86%

Hold

0.00%

Sell

Based on 14 analysts, 57.14% of analysts recommend a 'BUY' rating for 2seventy Bio Inc. Average target price of $5

2seventy Bio Inc Share Price Target

Get share price movements and forecasts by analysts on 2seventy Bio Inc.

What analysts predicted

0.2%UPSIDE

Target Price

Current Price

$4.99

Analyzed by

14 Analysts

Target

$5.00

2seventy Bio Inc target price $5, a slight upside of 0.2% compared to current price of $4.99. According to 14 analysts rating.

2seventy Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	56	41	36	12	10	12	8	13	2	2
Gross Profit	40	37	31	7	4	5	5	7	-5	-5
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-23	-42	-42	-71	-56	-52	24	-9	-19	-19
Net Profit Margin	-41.20%	-102.05%	-116.76%	-595.30%	-531.84%	-423.59%	277.45%	-73.39%	-667.12%	-667.12%

2seventy Bio Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	54	44	248	54	91	100	37
Gross Profit	53	41	242	52	65	83	15
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-199	-323	-138	-292	-254	-217	-57
Net Profit Margin	-365.98%	-729.96%	-55.69%	-535.95%	-277.77%	-216.73%	-151.20%

Global Institutional Holdings in 2seventy Bio Inc

Funds	Holdings
Kynam Capital Management, LP	11.19%
Goldman Sachs Group Inc	8.07%
BlackRock Inc	7.93%
Vanguard Group Inc	7.07%
Morgan Stanley - Brokerage Accounts	5.48%

See all

About 2seventy Bio Inc

2seventy bio, Inc. is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The Company is focused on the commercialization and development of Abecma (idecabtagene vicleucel). Abecma is its B cell maturation antigen (BCMA)-targeted CAR T cell therapy for multiple myeloma, in collaboration with their partner Bristol Myers Squibb (BMS). ABECMA is a BCMA-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. Abecma uses a lentiviral vector (LVV), to deliver a chimeric antigen receptor (CAR), with the potential to program a patient’s own T cells to recognize the plasma cell specific BCMA, protein on the cell surface.

Organisation	2seventy Bio Inc
E-voting on shares	Click here to vote

FAQs

What is 2seventy Bio Inc share price today?

2seventy Bio Inc share price today is $4.99 as on May 13, 2025 at 1:29 am IST at the close of the market. 2seventy Bio Inc share today touched a day high of $4.99 and a low of $4.99.

What is the 52 week high and 52 week low for 2seventy Bio Inc share?

2seventy Bio Inc share touched a 52 week high of $5.01 on May 6, 2025 and a 52 week low of $4.88 on April 8, 2025. 2seventy Bio Inc stock price today i.e. May 13, 2025 at 1:29 am IST is closed at $4.99,which is 0.40% down from its 52 week high and 2.25% up from its 52 week low.

How to invest in 2seventy Bio Inc Stock (TSVT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for 2seventy Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 2seventy Bio Inc Shares that will get you 0.3006 shares as per 2seventy Bio Inc share price of $4.99 per share as on May 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy 2seventy Bio Inc Stock (TSVT) from India?

Indian investors can start investing in 2seventy Bio Inc (TSVT) shares with as little as ₹92.369 or $1 (as of March 18, 2026 at 11:23 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹923.69 in 2seventy Bio Inc stock (as per the Rupee-Dollar exchange rate as on March 18, 2026 at 11:23 am IST). Based on 2seventy Bio Inc share’s latest price of $4.99 as on May 13, 2025 at 1:29 am IST, you will get 2.0040 shares of 2seventy Bio Inc. Learn more about fractional shares .